Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 10, 2022	SC 13G/A	An amendment to the SC 13G filing	0000093751-22-000122.pdf 0000093751-22-000122.rtf View HTML
June 9, 2022	SC 13G/A	An amendment to the SC 13G filing	0001104659-22-069630.pdf 0001104659-22-069630.rtf View HTML
January 20, 2023	SC 13G/A	An amendment to the SC 13G filing	0000093751-23-000018.pdf 0000093751-23-000018.rtf View HTML
February 9, 2023	SC 13G/A	An amendment to the SC 13G filing	0001104659-23-015229.pdf 0001104659-23-015229.rtf View HTML
February 10, 2023	SC 13G/A	An amendment to the SC 13G filing	0000895345-23-000072.pdf 0000895345-23-000072.rtf View HTML
February 9, 2024	SC 13G/A	An amendment to the SC 13G filing	0000895345-24-000039.pdf 0000895345-24-000039.rtf View HTML
February 13, 2024	SC 13G/A	An amendment to the SC 13G filing	0001104659-24-020210.pdf 0001104659-24-020210.rtf View HTML
March 31, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001104659-14-024204.pdf 0001104659-14-024204.rtf 0001104659-14-024204.xls View HTML
April 29, 2014	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001144204-14-025779.pdf 0001144204-14-025779.rtf 0001144204-14-025779.xls View HTML
January 6, 2015	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000790502-15-000007.pdf 0000790502-15-000007.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax